Mode
Text Size
Log in / Sign up

Ovarian Hyperstimulation Syndrome

Part of Adnexal Diseases

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ovarian Hyperstimulation Syndrome

2 trials tracked for Ovarian Hyperstimulation Syndrome: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 8 citations.

2Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Other / NA 1
  1. Phase 4 Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS Completed · 8 cited
  2. N/A The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Adnexal Diseases

Related studies from across the Adnexal Diseases family.

Narrative review links lactylation modification to gynecological disease pathogenesis and potential therapy
OB/GYN & Women's Health Meta-analysis
Narrative review links lactylation modification to gynecological disease pathogenesis and potential therapy New metabolic switch could help treat difficult gynecological conditions
This narrative review addresses the lack of systematic analysis on lactylation modification in gynecological diseases. The authors synthesiz…
A new cellular switch that uses energy to control genes might one day help doctors treat difficult gynecological conditions like endometrios…
Pembrolizumab Plus Paclitaxel Improves Survival in Recurrent Ovarian Carcinoma Compared to Paclitaxel Alone
Oncology RCT
Pembrolizumab Plus Paclitaxel Improves Survival in Recurrent Ovarian Carcinoma Compared to Paclitaxel Alone New Drug Combo Extends Survival for Tough Ovarian Cancer
This randomised, double-blind phase 3 study evaluated pembrolizumab plus paclitaxel versus placebo plus paclitaxel in 643 female participant…
This new combination offers a meaningful survival boost for women with recurrent ovarian cancer that has become resistant to standard treatm…
Residence in mining districts associated with higher hospitalization rates for uterine and ovarian pathologies among gynecological inpatients
OB/GYN & Women's Health Cohort
Residence in mining districts associated with higher hospitalization rates for uterine and ovarian pathologies among gynecological inpatients Mining Towns See More Gynecology Visits
This retrospective cross-sectional study examined 4,935 gynecological inpatients at a tertiary hospital in Heilongjiang Province, China.
Women in China's mining towns face higher rates of gynecological issues like fibroids and polyps, with hospitalization rates nearly five tim…